Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Jan 11, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Celsee said today that it has entered a co-commercialization agreement with IncellDx for several products, including a 20-marker lung cancer genomics and proteomics panel, a CTC-based screening test for breast, colorectal, prostate, and other cancers, and a cell-based NIPT assay.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Trump Announces Departure From WHO

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

Also, Vacuums Are Just Scary

A study of Great Danes homes in on a genomic region linked to fearfulness.

Limited Early Spread

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

PLOS Papers on Indonesian Archipelago Populations, Hookworm Secretome, Carotid Plaque GWAS

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.

What's Popular?

In Business News

  1. Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details

  2. Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

    Premium

  3. Sema4 Forms Coronavirus Testing Alliance With Connecticut

  4. Progenity Files for IPO, Seeks to Raise up to $100M

  5. New Products Posted to GenomeWeb: Qiagen Thermo Fisher Scientific, Bruker, More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.